UFP Technologies Announces Record Q2 Results

UFP Technologies reported record-breaking results for the second quarter ended June 30, 2026. Net sales increased by 15.1% to $174.0 million, and net income rose by 21.4% to $20.9 million, with diluted EPS at $2.68. For the first six months of 2026, net sales reached $328.2 million, up 9.6% from the previous year, and net income was $38.3 million, an 11.6% increase. The company highlighted strong performance across its platform, particularly in its MedTech business, with top five customers growing by 14.7% and the balance of the MedTech business increasing by 19.7%. Investments in Dominican Republic operations are noted to be generating early operational benefits. The company is focused on continued growth through existing customers, new program launches, strategic acquisitions, and investments in capabilities. Despite some mix and margin pressure in U.S. operations due to these investments, the company remains optimistic about future growth opportunities and long-term value creation.